Altshuler Shaham’s Guardant Health GH Stock Holding History

Altshuler Shaham’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-286	Closed	-$44K	–	655
2021 Q1	$44K	Buy	+286	New	+$43.2K	﹤0.01%	303

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Altshuler Shaham's GH Position: Q2 2021 in Review

Altshuler Shaham sold out of Guardant Health (GH) in Q2 2021, closing a stake of 286 shares — an estimated $44K sold.

Altshuler Shaham first reported a position in GH in Q1 2021 and held it in 1 quarter. The position peaked at $44K in Q1 2021. 416 funds tracked by Wall St. Rank hold GH as of Q2 2021.

Altshuler Shaham reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
Altshuler Shaham sold 286 Guardant Health shares in Q2 2021, an estimated $44K.
Altshuler Shaham first reported a position in Guardant Health in Q1 2021 and held it in 1 quarter.
Altshuler Shaham's Guardant Health position peaked at $44K in Q1 2021.
416 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Altshuler Shaham's 13F filing for Q2 2021, filed 16 Aug 2021.